Fusion Pharmaceuticals Inc (FUSN)
21.50
+0.04
(+0.19%)
USD |
NASDAQ |
May 17, 16:00
21.50
0.00 (0.00%)
Pre-Market: 20:00
Fusion Pharmaceuticals Total Return Level: 21.51 for May 17, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 17, 2024 | 21.51 |
May 16, 2024 | 21.46 |
May 15, 2024 | 21.54 |
May 14, 2024 | 21.43 |
May 13, 2024 | 21.43 |
May 10, 2024 | 21.48 |
May 09, 2024 | 21.38 |
May 08, 2024 | 21.40 |
May 07, 2024 | 21.40 |
May 06, 2024 | 21.42 |
May 03, 2024 | 21.45 |
May 02, 2024 | 21.49 |
May 01, 2024 | 21.42 |
April 30, 2024 | 21.43 |
April 29, 2024 | 21.40 |
April 26, 2024 | 21.42 |
April 25, 2024 | 21.40 |
April 24, 2024 | 21.40 |
April 23, 2024 | 21.42 |
April 22, 2024 | 21.32 |
April 19, 2024 | 21.26 |
April 18, 2024 | 21.25 |
April 17, 2024 | 21.24 |
April 16, 2024 | 21.26 |
April 15, 2024 | 21.28 |
Date | Value |
---|---|
April 12, 2024 | 21.31 |
April 11, 2024 | 21.36 |
April 10, 2024 | 21.36 |
April 09, 2024 | 21.38 |
April 08, 2024 | 21.40 |
April 05, 2024 | 21.32 |
April 04, 2024 | 21.43 |
April 03, 2024 | 21.34 |
April 02, 2024 | 21.29 |
April 01, 2024 | 21.25 |
March 28, 2024 | 21.32 |
March 27, 2024 | 21.30 |
March 26, 2024 | 21.30 |
March 25, 2024 | 21.18 |
March 22, 2024 | 21.24 |
March 21, 2024 | 21.20 |
March 20, 2024 | 21.09 |
March 19, 2024 | 21.18 |
March 18, 2024 | 10.64 |
March 15, 2024 | 9.99 |
March 14, 2024 | 9.34 |
March 13, 2024 | 9.50 |
March 12, 2024 | 9.48 |
March 11, 2024 | 9.42 |
March 08, 2024 | 10.04 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.98
Minimum
Nov 07 2022
21.54
Maximum
May 15 2024
7.625
Average
7.15
Median
Total Return Level Benchmarks
AstraZeneca PLC | 220.20 |
Landos Biopharma Inc | 22.47 |
Perspective Therapeutics Inc | 1.60 |
Acasti Pharma Inc | 2.69 |
Aurinia Pharmaceuticals Inc | 5.76 |